Malignant Duodenal Neoplasm — Trials

Malignant Duodenal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 18
Recruiting: 13
Ph III recruiting: 3
Growth YoY: —
Industry share: 0%
Top sponsor: Minia University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00987766	Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer	completed	Phase 1	28	Vanderbilt-Ingram Cancer CenterOTHER	1	Jul 2, 2017	clinicaltrials
NCT00983268	Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer	completed	Phase 1	21	Vanderbilt-Ingram Cancer CenterOTHER	1	Jun 15, 2015